Gen Digital Inc header image

Gen Digital Inc

GEN

Equity

ISIN null / Valor 50784395

NASDAQ (2025-11-17)
USD 26.14-2.10%

Gen Digital Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Gen Digital Inc. (NASDAQ: GEN) is a global technology company specializing in digital security, privacy, identity protection, and financial wellness solutions. Through its portfolio of trusted brands—including Norton, Avast, LifeLock, MoneyLion, Avira, AVG, CCleaner, GOBankingRates, and ReputationDefender—Gen serves nearly 500 million users across more than 150 countries. The company's cybersecurity offerings leverage advanced machine learning and artificial intelligence to detect and mitigate online threats in real time, while its identity protection services, led by LifeLock, provide comprehensive monitoring and restoration assistance for individuals facing identity theft. Additionally, MoneyLion delivers digital financial services aimed at enhancing financial health for its users. By partnering with leading institutions across various industries, Gen Digital Inc. delivers integrated solutions that support both consumer and business needs in an increasingly digital landscape.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (11.11.2025):

Gen Digital Inc released its Q1 Fiscal Year 2026 financial results (ended July 4, 2025) with better-than-expected performance, driven by robust revenue growth, strong operating cash flow, and an expanding portfolio in cybersecurity and trust-based solutions. The company not only surpassed GAAP and non-GAAP benchmarks but also raised its annual guidance and announced a quarterly cash dividend, underscoring its commitment to sustainable growth.

Revenue and Earnings Growth

In Q1 FY26, Gen Digital Inc reported GAAP revenue of $1,257 million—up 30%—and GAAP operating income of $446 million, while operating cash flow surged by 55% to $409 million. On a non-GAAP basis, the company posted operating income of $650 million and saw diluted EPS rise by 20% to $0.64.

Operating Metrics and Bookings

The strong performance was further supported by non-GAAP bookings reaching $1,202 million, up 32%, highlighting the effective execution of the company's strategy in its Cyber Safety Platform and Trust-Based Solutions, even as operating margins experienced slight contractions.

Guidance and Dividend Update

Looking ahead, Gen Digital Inc raised its annual guidance with FY26 revenue expected between $4,800 million and $4,900 million and enhanced EPS forecasts. Additionally, Q2 FY26 is projected to deliver revenue in the range of $1,180 million to $1,210 million, and the Board approved a quarterly cash dividend of $0.125 per share.

Summarized from source with an LLMView Source

Key figures

-11.6%1Y
16.4%3Y
38.4%5Y

Performance

28.5%1Y
29.7%3Y
30.5%5Y

Volatility

Market cap

16121 M

Market cap (USD)

Daily traded volume (Shares)

5,772,872

Daily traded volume (Shares)

1 day high/low

27.52 / 27.04

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 178.27
STEMMER IMAGING AG
STEMMER IMAGING AG STEMMER IMAGING AG Valor: 40430134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 59.00